RT @flatironhealth: In collaboration w/ @US_FDA, @DanaFarber & @genentech, we evaluated different methods to collect outcomes from clinical…
RT @flatironhealth: With @US_FDA, we applied our method for capturing cancer progression from electronic health records (https://t.co/EgZWr…
RT @flatironhealth: With @US_FDA, we applied our method for capturing cancer progression from electronic health records (https://t.co/EgZWr…
RT @flatironhealth: With @US_FDA, we applied our method for capturing cancer progression from electronic health records (https://t.co/EgZWr…
RT @flatironhealth: With @US_FDA, we applied our method for capturing cancer progression from electronic health records (https://t.co/EgZWr…
With @US_FDA, we applied our method for capturing cancer progression from electronic health records (https://t.co/EgZWrXAFvP) to thousands of patients w/ advanced non-small cell lung cancer treated with PD-1/PD-L1 inhibitors. In @JournalCancer: https://t.c
RT @flatironhealth: In collaboration w/ @US_FDA, @DanaFarber & @genentech, we evaluated different methods to collect outcomes from clinical…
RT @flatironhealth: In collaboration w/ @US_FDA, @DanaFarber & @genentech, we evaluated different methods to collect outcomes from clinical…
In collaboration w/ @US_FDA, @DanaFarber & @genentech, we evaluated different methods to collect outcomes from clinical reports available in the EHR to better understand cancer progression @AdvancesTherapy https://t.co/EgZWrXAFvP https://t.co/hB4kjLKGH
Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer. https://t.co/AXyqrsD9QY
#ehr "Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer." https://t.co/CVkfDlBXL